WSC
PJP icon

Wellington Shields & Co’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Wellington Shields & Co’s Portfolio PJP Stock Details PJP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,043
Closed -$316K – 335
2026
Q1 		$316K Buy
+3,043
New +$321K 0.08% 193

Other funds holding PJP

PAM
Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
MML Investors Services
MML Investors Services Springfield, Massachusetts $49B AUM 25.55% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
JGCM
Joseph Group Capital Management Columbus, Ohio $476M AUM 21.21% 1-Year Est. Return

Wellington Shields & Co's PJP Position: Q2 2026 in Review

Wellington Shields & Co sold out of Invesco Pharmaceuticals ETF (PJP) in Q2 2026, closing a stake of 3,043 shares — an estimated $316K sold.

Wellington Shields & Co first reported a position in PJP in Q1 2026 and held it in 1 quarter. The position peaked at $316K in Q1 2026. 117 funds tracked by Wall St. Rank hold PJP as of Q2 2026.

  • Wellington Shields & Co reported no remaining Invesco Pharmaceuticals ETF position as of Q2 2026 after selling out during the quarter.
  • Wellington Shields & Co sold 3,043 Invesco Pharmaceuticals ETF shares in Q2 2026, an estimated $316K.
  • Wellington Shields & Co first reported a position in Invesco Pharmaceuticals ETF in Q1 2026 and held it in 1 quarter.
  • Wellington Shields & Co's Invesco Pharmaceuticals ETF position peaked at $316K in Q1 2026.
  • 117 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2026.

Based on Wellington Shields & Co's 13F filing for Q2 2026, filed 10 Aug 2026.